{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:30:39Z","timestamp":1792467039508,"version":"4.5.0"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC 310857"],"award-info":[{"award-number":["ERC 310857"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001821","name":"Vienna Science and Technology Fund","doi-asserted-by":"publisher","award":["WWTF-LS16-060"],"award-info":[{"award-number":["WWTF-LS16-060"]}],"id":[{"id":"10.13039\/501100001821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01978","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T04:14:32Z","timestamp":1516248872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Human NF-\u03baB1 Haploinsufficiency and Epstein\u2013Barr Virus-Induced Disease\u2014Molecular Mechanisms and Consequences"],"prefix":"10.3389","volume":"8","author":[{"given":"Birgit","family":"Hoeger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina Kathrin","family":"Serwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaan","family":"Boztug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-kappaB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"a000182","DOI":"10.1101\/cshperspect.a000182","article-title":"Roles of the NF-kappaB pathway in lymphocyte development and function","volume":"2","author":"Gerondakis","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-065X.2012.01106.x","article-title":"NF-kappaB function in B lymphocytes","volume":"246","author":"Kaileh","year":"2012","journal-title":"Immunol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.1038\/sj.onc.1209944","article-title":"Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models","volume":"25","author":"Gerondakis","year":"2006","journal-title":"Oncogene"},{"key":"B5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","article-title":"Haploinsufficiency of the NF-kappaB1 subunit p50 in common variable immunodeficiency","volume":"97","author":"Fliegauf","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaci.2016.05.045","article-title":"Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1-mutated common variable immunodeficiency disease","volume":"139","author":"Lougaris","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10875-016-0306-1","article-title":"NF-kappaB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation","volume":"36","author":"Boztug","year":"2016","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.3324\/haematol.2016.145136","article-title":"Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans","volume":"101","author":"Schipp","year":"2016","journal-title":"Haematologica"},{"key":"B9","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaci.2016.10.054","article-title":"Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes","volume":"140","author":"Kaustio","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jaci.2016.04.043","article-title":"Disturbed canonical nuclear factor of kappa light chain signaling in B cells of patients with common variable immunodeficiency","volume":"139","author":"Keller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1038\/cti.2017.38","article-title":"Autoimmunity\/inflammation in a monogenic primary immunodeficiency cohort","volume":"6","author":"Rae","year":"2017","journal-title":"Clin Transl Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clim.2016.11.012","article-title":"NFKB1 regulates human NK cell maturation and effector functions","volume":"175","author":"Lougaris","year":"2017","journal-title":"Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2017-05-782177","article-title":"Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype","volume":"130","author":"Kuehn","year":"2017","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","article-title":"Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency","volume":"93","author":"Chen","year":"2013","journal-title":"Am J Hum Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12881-014-0139-9","article-title":"Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies","volume":"15","author":"Brue","year":"2014","journal-title":"BMC Med Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s10875-014-0064-x","article-title":"Novel NFKB2 mutation in early-onset CVID","volume":"34","author":"Liu","year":"2014","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1182\/blood-2014-06-578542","article-title":"Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12026-014-8496-1","article-title":"The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease","volume":"58","author":"Hatton","year":"2014","journal-title":"Immunol Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.biocel.2007.05.004","article-title":"Nuclear factor-kappaB1: regulation and function","volume":"40","author":"Pereira","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/febs.13627","article-title":"NFKB1: a suppressor of inflammation, ageing and cancer","volume":"283","author":"Cartwright","year":"2016","journal-title":"FEBS J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity","volume":"18","author":"Karin","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nri2423","article-title":"New regulators of NF-kappaB in inflammation","volume":"8","author":"Ghosh","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/ni.1639","article-title":"The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors","volume":"9","author":"Pobezinskaya","year":"2008","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1002\/j.1460-2075.1996.tb01007.x","article-title":"RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas\/APO-1-initiated apoptosis","volume":"15","author":"Ting","year":"1996","journal-title":"EMBO J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/383443a0","article-title":"TRAF6 is a signal transducer for interleukin-1","volume":"383","author":"Cao","year":"1996","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/35006090","article-title":"PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes","volume":"404","author":"Sun","year":"2000","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/ni823","article-title":"PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling","volume":"3","author":"Su","year":"2002","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"26243","DOI":"10.1074\/jbc.M403286200","article-title":"Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation","volume":"279","author":"Liao","year":"2004","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","article-title":"NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100","volume":"7","author":"Xiao","year":"2001","journal-title":"Mol Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1038\/sj.onc.1209933","article-title":"Transcriptional regulation via the NF-kappaB signaling module","volume":"25","author":"Hoffmann","year":"2006","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-kappaB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/1521-4141(2000)30:8<2323::AID-IMMU2323>3.0.CO;2-H","article-title":"Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis","volume":"30","author":"Barton","year":"2000","journal-title":"Eur J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1084\/jem.20022234","article-title":"Differential requirement for Rel\/nuclear factor kappa B family members in natural killer T cell development","volume":"197","author":"Sivakumar","year":"2003","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1182\/blood-2003-08-2975","article-title":"Combined deficiency in IkappaBalpha and IkappaBepsilon reveals a critical window of NF-kappaB activity in natural killer cell differentiation","volume":"103","author":"Samson","year":"2004","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nri1629","article-title":"Control of lymphocyte development by nuclear factor-kappaB","volume":"5","author":"Siebenlist","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1084\/jem.20020907","article-title":"IkappaB kinase signaling is essential for maintenance of mature B cells","volume":"196","author":"Pasparakis","year":"2002","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fimmu.2014.00415","article-title":"Comparison of diagnostic criteria for common variable immunodeficiency disorder","volume":"5","author":"Ameratunga","year":"2014","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-385991-4.00002-7","article-title":"\u201cA rose is a rose is a rose,\u201d but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011?","volume":"111","author":"Yong","year":"2011","journal-title":"Adv Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/asheducation-2012.1.301","article-title":"The many faces of common variable immunodeficiency","volume":"2012","author":"Cunningham-Rundles","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0092-8674(95)90415-8","article-title":"Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses","volume":"80","author":"Sha","year":"1995","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.156.1.183","article-title":"B cells from p50\/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching","volume":"156","author":"Snapper","year":"1996","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","article-title":"NF-kappaB in immunobiology","volume":"21","author":"Hayden","year":"2011","journal-title":"Cell Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0161-5890(99)00031-0","article-title":"An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets","volume":"36","author":"Bendall","year":"1999","journal-title":"Mol Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jaci.2014.11.038","article-title":"Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease","volume":"135","author":"Lougaris","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s10875-014-0095-3","article-title":"Combined immune deficiency in a patient with a novel NFKB2 mutation","volume":"34","author":"Lindsley","year":"2014","journal-title":"J Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e5081","DOI":"10.1097\/MD.0000000000005081","article-title":"NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency: a case report and review of literature","volume":"95","author":"Shi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: Classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncol"},{"key":"B51","first-page":"2655","volume-title":"Fields Virology","author":"Rickinson","year":"2007"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1038\/emm.2014.105","article-title":"Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorders","volume":"47","author":"Cai","year":"2015","journal-title":"Exp Mol Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1600-065X.1999.tb01328.x","article-title":"Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation","volume":"170","author":"Khanna","year":"1999","journal-title":"Immunol Rev"},{"key":"B54","doi-asserted-by":"publisher","first-page":"189096","DOI":"10.1155\/2012\/189096","article-title":"CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis","volume":"2012","author":"Pender","year":"2012","journal-title":"Autoimmune Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1084\/jem.20161846","article-title":"Human immunity against EBV-lessons from the clinic","volume":"214","author":"Tangye","year":"2017","journal-title":"J Exp Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bjh.12422","article-title":"Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases","volume":"162","author":"Parvaneh","year":"2013","journal-title":"Br J Haematol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.critrevonc.2016.10.014","article-title":"Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders","volume":"108","author":"Shabani","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-3-319-22822-8_10","article-title":"Primary immunodeficiencies associated with EBV disease","volume":"390","author":"Cohen","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/cid\/cir610","article-title":"Severe viral infections and primary immunodeficiencies","volume":"53","author":"Dropulic","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015","volume":"35","author":"Picard","year":"2015","journal-title":"J Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1172\/JCI37901","article-title":"Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation","volume":"119","author":"Huck","year":"2009","journal-title":"J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3324\/haematol.2012.068791","article-title":"Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27","volume":"98","author":"Salzer","year":"2013","journal-title":"Haematologica"},{"key":"B66","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20160784","article-title":"Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection","volume":"214","author":"Izawa","year":"2017","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1084\/jem.20160849","article-title":"Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency","volume":"214","author":"Abolhassani","year":"2017","journal-title":"J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jaci.2013.01.042","article-title":"Whole-exome sequencing identifies Coronin-1A deficiency in 3 siblings with immunodeficiency and EBV-associated B-cell lymphoproliferation","volume":"131","author":"Moshous","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/ni.3575","article-title":"RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics","volume":"17","author":"Salzer","year":"2016","journal-title":"Nat Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","article-title":"XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/nyas.12937","article-title":"Primary immunodeficiencies and the control of Epstein-Barr virus infection","volume":"1356","author":"Palendira","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1006\/smim.1998.0154","article-title":"Control of lymphocyte function through CD27-CD70 interactions","volume":"10","author":"Lens","year":"1998","journal-title":"Semin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jaci.2004.01.762","article-title":"The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation","volume":"113","author":"Orange","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1038\/ncomms6360","article-title":"Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity","volume":"5","author":"Willmann","year":"2014","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2015.09.001","article-title":"The effects of RelB deficiency on lymphocyte development and function","volume":"65","author":"Sharfe","year":"2015","journal-title":"J Autoimmun"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1309199","article-title":"Deficiency of innate and acquired immunity caused by an IKBKB mutation","volume":"369","author":"Pannicke","year":"2013","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s10875-014-0097-1","article-title":"Immunodeficiency associated with a nonsense mutation of IKBKB","volume":"34","author":"Nielsen","year":"2014","journal-title":"J Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/PL00000776","article-title":"The CD40\/CD154 receptor\/ligand dyad","volume":"58","author":"Schonbeck","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"B79","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/361539a0","article-title":"Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM","volume":"361","author":"Korthauer","year":"1993","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.7679801","article-title":"CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome","volume":"259","author":"Allen","year":"1993","journal-title":"Science"},{"key":"B81","doi-asserted-by":"publisher","first-page":"12614","DOI":"10.1073\/pnas.221456898","article-title":"Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM","volume":"98","author":"Ferrari","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1073\/pnas.1120542109","article-title":"Genome-wide siRNA screen for mediators of NF-kappaB activation","volume":"109","author":"Gewurz","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B83","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1182\/blood-2010-12-323154","article-title":"Immunotherapeutic effects of IL-7 during a chronic viral infection in mice","volume":"117","author":"Nanjappa","year":"2011","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","first-page":"10029","DOI":"10.1128\/JVI.02241-06","article-title":"Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells","volume":"81","author":"Zou","year":"2007","journal-title":"J Virol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest"},{"key":"B86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00018-013-1545-4","article-title":"NF-kappaB pathways in hematological malignancies","volume":"71","author":"Gasparini","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"B88","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1128\/MCB.19.9.5923","article-title":"NF-kappaB induces expression of the Bcl-2 homologue A1\/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis","volume":"19","author":"Wang","year":"1999","journal-title":"Mol Cell Biol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B90","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/j.1460-2075.1994.tb06329.x","article-title":"Calcineurin acts in synergy with PMA to inactivate I kappa B\/MAD3, an inhibitor of NF-kappa B","volume":"13","author":"Frantz","year":"1994","journal-title":"EMBO J"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1126\/science.1260791","article-title":"Immunology. Autoimmunity by haploinsufficiency","volume":"345","author":"Rieux-Laucat","year":"2014","journal-title":"Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T15:48:46Z","timestamp":1693496926000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":91,"alternative-id":["10.3389\/fimmu.2017.01978"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01978","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"article-number":"1978"}}